European shares slip as healthcare stocks weigh, France in focus

European equities experienced choppy trading on Friday, with the STOXX 600 closing slightly lower, primarily weighed down by declines in healthcare and luxury sectors, and anticipation of Fitch's French credit rating review. Despite this, the benchmark is poised for its first weekly gain in three weeks, largely fueled by heightened market expectations for a Federal Reserve rate cut next week following recent U.S. labor data. Geopolitical tensions also drove significant weekly gains in the aerospace and defense sector, while French stocks outperformed the broader STOXX index weekly, benefiting from a valuation discount and international market exposure despite domestic political challenges.

Analysis

European equity markets exhibited conflicting signals, with the STOXX 600 index declining 0.2% on Friday but remaining on track for its first weekly gain in three weeks. The daily pullback was primarily driven by sector-specific weakness, as healthcare stocks fell 0.6%—led by Novartis's 2.6% drop after a Goldman Sachs downgrade citing generic competition—and the luxury sector declined 1% following a UBS report designating it a 'least preferred' area. Conversely, the market's weekly strength is attributed to macroeconomic optimism, with weakening U.S. labor data cementing expectations for a Federal Reserve rate cut. This contrasts with the European Central Bank's static policy posture. Geopolitical tensions provided a significant tailwind for the aerospace and defense sector, which rallied 5.4% for the week. Notably, French equities are set to outperform with a 1.3% weekly gain, buoyed by a valuation discount and the international revenue base of its large-cap companies, despite imminent sovereign risk from a Fitch credit rating review and domestic political instability. On a micro level, idiosyncratic risks were evident, with Ocado sliding 10% after its partner Kroger announced a review of warehouse investments.

Key Decisions for Investors

• Investors should re-evaluate exposure to European healthcare and luxury sectors, as firms like Novartis and LVMH face headwinds from analyst downgrades and concerns over competition.
• Monitor the aerospace and defense sector, which is showing strong momentum driven by escalating geopolitical events, representing a potential tactical allocation.
• Consider the relative value in the French equity market, which has outperformed despite domestic political risks, but remain alert to potential volatility from the upcoming Fitch sovereign credit rating review.
• Be cautious of idiosyncratic risks, as exemplified by Ocado's 10% decline on partner-related news, which can override broader positive market sentiment driven by expected U.S. Federal Reserve easing.